PTGX: Protagonist Therapeutics Company Short-Term Debt
High R&D expenditures and peptide patent protection create significant barriers to entry for competitors. The evolution of short-term debt load on the GURU.Markets chart visualizes this process, where the latest value is recorded as 0.00. Primary risks are linked to potential FDA trial failures, while the geopolitical status of the drugs minimizes external pressure on Protagonist Therapeutics (PTGX).
Metric breakdowns and analytics for Protagonist Corp (PTGX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Protagonist Therapeutics|PTGX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Protagonist Therapeutics|PTGX - Company Total Debt|Debt to Book Capitalization Ratio Protagonist|PTGX - Company Long-Term Liabilities|Company Current Liabilities Protagonist Therapeutics|Quick Liquidity protagonist-inc.com
- net income and valuation multiples indicators:
Initial company analysis:PTGX - Protagonist
The financial stability of Protagonist Therapeutics (PTGX) depends on its ability to service obligations due within one year, which is reflected in the company's short-term liability structure. This indicator aggregates all current debts to assess the risk of cash flow gaps, particularly given the high costs of energy-efficient laboratories and sustainable peptide synthesis, directly impacting the calculation of the fair value of assets.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|IMVT (Immunovant, Inc.) - Company Short-Term Debts|Company Short-Term Debts kiniksa.com|Company Current Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLDX (Celldex)|Short-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Short-Term Debt|veratx.com (VERA) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|Current Liabilities IMNM|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|kalvista.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Septerna|Short-Term Debt Pieris Pharma PVLA|Company Current Liabilities SVRA (Savara Corp)|Amount of Current Liabilities RIGL|Company Short-Term Debts ANAB (AnaptysBio, Inc.)|Company Short-Term Debts astriatx.com ATXS|enGene - Company Short-Term Debts|Short-Term Indebtedness rapt.com (RAPT)|aerovatetx.com (JBIO) - Company Short-Term Debt|Short-Term Debt Aclaris Therapeutics, Inc (ACRS)|Company Short-Term Debt Kyverna Therapeutics|Company Short-Term Indebtedness TLSA (tizianalifesciences.com)|Company Short-Term Debts CABA|Short-Term Debt Volume Ventyx Biosciences Inc.|Company Short-Term Debt Theratechnologies Inc THTX|Short-Term Debt Volume Avalo Therapeutics Inc (AVTX)|ELDN: Company Current Liabilities|agenusbio.com - Amount of Current Liabilities|CLYM (Climb Bio) - Company Current Liabilities|zurabio.com - Company Short-Term Loans and Borrowings|Company Current Liabilities ATYR|ADAG (Adagene Corp) - Amount of Current Liabilities|Company Short-Term Debts IMA|STTK (shattucklabs.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|IMUX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ATRA (Atara Biotherapeutics)|IFRX: Company Short-Term Debts|x4pharma.com (XFOR) - Company Short-Term Debts|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp - Current Liabilities|Company Short-Term Debts INMB|BRNS - Short-Term Debt|Kezar Life Sciences - Company Current Liabilities|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX: Company Current Liabilities|Enlivex Therapeutics - Amount of Current Liabilities|QTTB: Company Short-Term Debts|GOVX - Short-Term Debt Volume|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Current Liabilities ibioinc.com (IBIO)|Company Short-Term Debt Carisma Therapeutics (CARM)|Short-Term Debt Volume XTL Biopharmaceuticals Ltd|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|APVO: Company Current Liabilities|aimimmuno.com - Amount of Current Liabilities|ADTX: Company Short-Term Debts|Short-Term Indebtedness GRI Bio Inc GRI|Company Current Liabilities XRTX|Company Short-Term Indebtedness HIND (Vyome Therapeutics)|Company Short-Term Debt Revelation Biosciences (REVB)|INDP: Current Liabilities|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|ALLK - Company Short-Term Debts|hookipapharma.com (HOOK) - Company Short-Term Debt|IGM Biosciences - Company Short-Term Loans and Borrowings|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc (THRD)